CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
December 19 2017 - 4:01PM
Business Wire
CONMED Corporation (NASDAQ: CNMD) today announced that
Curt R. Hartman, President and Chief Executive Officer, and Luke A.
Pomilio, Chief Financial Officer, will present at the 36th Annual
J.P. Morgan Healthcare Conference at 4:00 p.m. PT on Wednesday,
January 10, 2018 in San Francisco, CA.
A live webcast of the presentation and Q&A breakout session
will be accessible through the “Investors” section of the Company’s
website at www.conmed.com and will be available for replay
following the event.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery and gastroenterology. CONMED has a direct selling
presence in 17 countries, and international sales constitute
approximately 50% of the Company’s total sales. Headquartered in
Utica, New York, the Company employs approximately 3,300 people.
For more information, visit www.conmed.com.
Forward-Looking Statements
This press release contains forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31,
2016. Any and all forward-looking statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 and relate to the Company’s performance on a
going-forward basis. The Company believes that all forward-looking
statements made by it have a reasonable basis, but there can be no
assurance that management’s expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or
prove to be correct.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171219006042/en/
CONMED CorporationLuke A. Pomilio,
315-624-3202Chief Financial Officer
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Sep 2023 to Sep 2024